Your Path to Hope Resources

After a diagnosis of brain cancer, it is likely that surgery or some other treatment will be recommended to remove or shrink the tumor. These treatments can sometimes alter a patient’s mental status and/or ability to communicate. This possibility makes it all the more important for families to consider executing various legal documents to ensure that a patient’s wishes are honored. While it may seem morbid to discuss what treatments or measures should be taken to keep someone alive or comfortable, these documents can help provide guidance and reassurance for …

The Ivy Brain Tumor Center at Barrow Neurological Institute and SonALAsense announced positive results in their first-in-human Phase 0/1 clinical trial of SDT in recurrent glioblastoma patients. The initial results were presented at the European Society for Medical Oncology Congress today by Nader Sanai, MD, Director of the Ivy Brain Tumor Center. “The Ivy Center’s Phase 0/1 study has shown a promising translation of the preclinical results of SDT in patients with glioblastoma.

Since I started my training, there was the establishment of what’s currently the standard of care. Which is the concurrent use of radiation and temozolomide and adjuvant temozolomide. That, unfortunately, has not changed though, in the last 15 years. So although I got to see the transformation of the field and maybe for the first time, a large number of patients who have five years and beyond survival, we still have not been able to really make that a reality for a majority of patients. So we’ve unfortunately had some limitations in the advancements since that time.

Brains for the Cure (BFTC) is an online navigator designed to lend a helping hand throughout one’s brain tumor journey as they advocate for themselves, become educated on the latest research and treatments, and connect with others through Ambassadors, online support groups, and stories.

Today, July 21st, marks the 3rd Annual Glioblastoma (GBM) Awareness Day. Brains for the Cure invites you to join us, Head for the Cure, and the entire brain tumor community on honoring this important day! …

Medulloblastoma is a deadly form of pediatric brain cancer that strikes the cerebellum, a brain structure near the base of the skull. When it spreads to the lining of the brain or spinal cord, it …

Written by Lisa Lenrow | Brains for the Cure Ambassador I got married late in life, having met my husband at 49. Three years after our blind date, Jon proposed.  As I had been dreaming about …

“Why did this happen to me” is the kind of thing anybody might ask themself when faced with something as unwelcome as a brain tumor. You might recall choices and circumstances in your life, looking …

Today, May 10th, marks Ependymoma Awareness Day! May 10th was chosen to bring more awareness to this rare brain tumor type because of the 10 different molecular groups of ependymoma. What is an ependymoma? According …

Clinical trials are critical in finding new and better treatment options for brain tumors. Dr. Edward Pan from UT Southwestern Medical Center wants to clear up some misconceptions surrounding clinical trials. In almost all clinical …